Association between Dyslipidemia and Peritoneal Dialysis Technique Survival
- PMID: 31666849
- PMCID: PMC6814482
- DOI: 10.3889/oamjms.2019.664
Association between Dyslipidemia and Peritoneal Dialysis Technique Survival
Abstract
Background: A large body of research has investigated the effects of pro-atherogenic lipid profile on cardiovascular diseases (CVD) in peritoneal dialysis (PD) patients. However, there is a general lack of research on the association between atherogenic dyslipidemia and PD technique survival.
Aim: The study aimed to define the association between dyslipidemia and PD technique survival.
Methods: It was a prospective single-centre observational study involving 40 outpatients on continuous ambulatory PD treatment for more than 3 months between 2010 and 2016 in a single centre in Ukraine. There were 27 males and 13 females. The mean age of the participants was 49.3 ± 12.2 years. The primary outcome measures were all-cause technique failure.
Results: Atherogenic dyslipidemia was identified in 28/40 (70 %) patients and correlated with PD adequacy parameters. During the 36-month- follow-up period technique failure occurred in 2/12 (16.6 %) patients with atherogenic dyslipidemia compared with 12 / 28 (42.9 %) patients without atherogenic dyslipidemia (χ2 = 2.5; p = 0.12). In the univariate Cox regression model, atherogenic dyslipidemia at baseline was significantly associated with a higher risk of all-cause PD technique failure (HR 4.5; 95% CI 1.6 to 12.9; χ2 = 5.5, p = 0.019).
Conclusion: The presence of atherogenic dyslipidemia was significantly associated with a higher risk of technique failure in PD patients. This is an important issue for future research. Further well-designed clinical trials are needed to determine the impact of dyslipidemia on PD adequacy and technique survival.
Keywords: Atherogenic dyslipidemia; PD adequacy; Peritoneal dialysis; Technique failure; Technique survival.
Copyright: © 2019 Natalia Stepanova, Olena Burdeyna.
Figures
References
-
- Barone R, Cámpora M, Gimenez N, Ramirez L, Panese S, Santopietro M. Peritoneal Dialysis as a first versus second option after previous haemodialysis:a very long-term assessment. Int J Nephrol. 2014;2014:693670. https://doi.org/10.1155/2014/693670 PMid:25505992 PMCid:PMC4258321. - PMC - PubMed
-
- Jain AK, Blake P, Cordy P, Garg AX. Global trends in rates of peritoneal dialysis. J Am Soc Nephrol. 2012;23(3):533–533. https://doi.org/10.1681/ASN.2011060607 PMid:22302194 PMCid:PMC3294313. - PMC - PubMed
-
- Kolesnyk I, Noordzij M, Kolesnyk M, Kulyzky M, Jager K. Renal replacement therapy in Ukraine:epidemiology and international comparisons. Clin Kidney J. 2014;7(3):330–330. https://doi.org/10.1093/ckj/sfu037 PMid:25852905 PMCid:PMC4377756. - PMC - PubMed
-
- Velloso MS, Otoni A, de Paula Sabino A, de Castro WV, Pinto SW, Marinho MA, et al. Peritoneal dialysis and inflammation. Clin Chim Acta. 2014;430:109–14. https://doi.org/10.1016/j.cca.2013.12.003 PMid:24333488. - PubMed
-
- Cho Y, Hawley CM, Johnson DW. Clinical causes of inflammation in peritoneal dialysis patients. Int J Nephrol. 2014;2014:909373. https://doi.org/10.1155/2014/909373 PMid:24895536 PMCid:PMC4033334. - PMC - PubMed
LinkOut - more resources
Full Text Sources